…
Strategem Capital Corporation invests in resource exploration and development, mining, energy production, and agricultural protein products in Canada. The company was formerly known as Dexton Technologies Corporation and changed its name to Strategem Capital Corporation in November 2001. Strategem Capital Corporation was incorporated in 1994 and is headquartered in Calgary, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Strategem Capital Corp. (SGE.V) is a small-cap Canadian public company listed on the TSX Venture Exchange; public filings are limited and the company describes itself as an investment/merchant vehicle pursuing acquisitions and capital deployment. Long-term growth may depend on successful deal execution, effective portfolio management and broader small‑cap market conditions, which could support asset appreciation and expanded operations, and may benefit investors seeking exposure to early-stage investment vehicles.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 0.47M | 0.64M | -1.73M | -20.35M | 10.54M |
| Net income | 0.47M | 0.64M | -1.73M | -17.63M | 8.28M |
| Selling general administrative | 0.41M | 0.30M | 0.37M | 0.42M | 1.33M |
| Gross profit | 0.16M | 0.48M | 0.17M | -19.89M | 11.86M |
| Ebit | - | - | - | -20.34M | 10.56M |
| Ebitda | - | - | - | -20.31M | 10.53M |
| Operating income | 0.49M | 0.64M | -1.72M | -20.31M | 10.53M |
| Interest expense | 0.00M | 0.03M | 0.00M | - | 0.00M |
| Tax provision | - | - | 0.00M | -2.73M | 2.25M |
| Net interest income | 0.00M | -0.03M | 0.00M | - | - |
| Income tax expense | - | - | - | -2.73M | 2.25M |
| Total revenue | 0.18M | 0.52M | 0.48M | -19.57M | 11.99M |
| Total operating expenses | -0.32M | -0.12M | 2.20M | 0.73M | 1.46M |
| Cost of revenue | 0.02M | 0.03M | 0.31M | 0.31M | 0.13M |
| Total other income expense net | -0.02M | 0.04M | -0.01M | -0.04M | 0.01M |
| Net income from continuing ops | 0.47M | 0.64M | -1.73M | -17.63M | 8.28M |
| Net income applicable to common shares | - | - | - | -17.63M | 8.28M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 10.92M | 10.42M | 9.81M | 11.65M | 33.12M |
| Total liab | 0.05M | 0.03M | 0.03M | 0.05M | 3.66M |
| Total stockholder equity | 10.86M | 10.39M | 9.78M | 11.60M | 29.46M |
| Common stock | - | - | - | 11.60M | 11.83M |
| Capital stock | 11.47M | 11.47M | 11.51M | 11.60M | 11.83M |
| Retained earnings | -0.61M | -1.08M | -1.73M | 0.00M | 17.63M |
| Other liab | - | - | - | - | 2.73M |
| Cash | 0.92M | 0.69M | 0.23M | 1.78M | 2.12M |
| Total current liabilities | 0.05M | 0.03M | 0.03M | 0.05M | 0.94M |
| Total current assets | 10.92M | 10.42M | 9.81M | 11.65M | 33.12M |
| Net tangible assets | - | - | - | 11.60M | 29.46M |
| Short term investments | 10.00M | 9.73M | 9.58M | 9.87M | 30.96M |
| Net receivables | - | - | - | 0.00M | 0.04M |
| Accounts payable | 0.03M | 0.03M | 0.03M | 0.04M | 0.04M |
| Non current assets total | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Change to liabilities | - | - | - | 0.01M | 0.02M |
| Total cash from financing activities | 0.00M | -0.04M | -0.12M | -0.23M | 11.82M |
| Change to operating activities | - | - | - | -0.90M | 0.83M |
| Net income | 0.47M | 0.64M | -1.73M | -17.63M | 8.28M |
| Change in cash | 0.22M | 0.46M | -2.57M | -0.34M | -2.65M |
| Begin period cash flow | 0.69M | 0.23M | 2.87M | 2.12M | 4.77M |
| End period cash flow | 0.92M | 0.69M | 0.29M | 1.78M | 2.12M |
| Total cash from operating activities | 0.22M | 0.50M | -2.46M | -0.11M | -14.48M |
| Issuance of capital stock | - | - | - | 0.00M | 11.82M |
| Change to account receivables | - | - | 0.00M | 0.04M | -0.04M |
| Sale purchase of stock | 0.00M | -0.04M | -0.09M | - | - |
| Other cashflows from financing activities | - | - | - | -0.23M | -0.23M |
| Change to netincome | - | - | - | 18.36M | -23.57M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 0.02M | 0.00M | 0.12M | -0.85M | 0.81M |
| Other non cash items | 0.42M | 0.54M | -2.22M | 1.06M | -14.64M |
| Free cash flow | 0.22M | 0.50M | -2.46M | -0.11M | -14.48M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SGE Strategem Capital Corp |
- -% |
0.70 | 10.60 | - | 5.13 | 0.45 | 0.15 | 0.14 |
| PVF-UN Partners Value Investments LP |
0.49 3.16% |
16.00 | 175.06 | - | 5.81 | - | - | - |
| CTH CoTec Holdings Corp. |
- -% |
1.05 | - | 0.14 | 368.93 | 3.34 | 36.25 | 23.26 |
| PTF Pender Growth Fund VCC Inc |
- -% |
14.51 | - | - | 5.35 | 0.90 | 6.32 | 29.18 |
| SQG Spackman Equit |
0.01 4.17% |
0.12 | - | - | 6.86 | 2.68 | 4.06 | -1.45 |
Strategem Capital Corporation invests in resource exploration and development, mining, energy production, and agricultural protein products in Canada. The company was formerly known as Dexton Technologies Corporation and changed its name to Strategem Capital Corporation in November 2001. Strategem Capital Corporation was incorporated in 1994 and is headquartered in Calgary, Canada.
| Name | Title | Year Born |
|---|---|---|
| Ms. Jo-Anne O'Connor | CEO & Pres | 1960 |
| Ms. Carol Fozo C.M.A., CPA | CFO & Sec. | NA |
| Dr. John Waterer Ph.D. | Chief Science Officer, Director of Life Science and Member of Science & Tech. Advisory Committee | NA |
| Ms. Jo-Anne O'Connor | CEO & President | 1960 |
| Ms. Carol Fozo C.M.A., CPA | CFO & Secretary | NA |
| Mr. Gordon Flatt | Chair of Office of President, Director, Managing Partner & Chief Investment Strategist | NA |
| Mr. Gordon Flatt | Chair of Office of President, Managing Partner, Chief Investment Strategist & Director | NA |
| Ms. Jo-Anne O'Connor | CEO & President | 1961 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.